Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 116,100 shares, a growth of 1,175.8% from the November 30th total of 9,100 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is currently 0.1 days. Currently, 8.5% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Arcadia Biosciences in a report on Wednesday. They set a “sell” rating on the stock.

Arcadia Biosciences Price Performance

NASDAQ:RKDA traded up $0.02 on Thursday, reaching $6.20. The stock had a trading volume of 36,565 shares, compared to its average volume of 316,571. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31. The company has a market cap of $8.46 million, a price-to-earnings ratio of -1.45 and a beta of 1.19. The firm’s fifty day moving average is $4.30 and its two-hundred day moving average is $3.39.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.